IARC
IARC
Newsletter
|
Our Profile
|
Digital Library
|
Blog
Member Login
IARC
About
About Us
About IARCON
Diversity Equity & Inclusion at IARCON
Associates & Partners
FAQ
Committies
Client Stories
Speakers
Blog
Committees
Client Stories
Blog
Speakers
Membership
Member Login
About Membership
Apply Membership
Dignitary Membership
Executive Membership
Ambassador Membership
Membership FAQ
Join Membership
Member Login
Dignitary Members
Executive Members
Communities
About connect2science
Faculty Chapters
ASN’s Chapters
IAR Artisan
eMAPILS
Conference
Plan Scientific Conference
Awards & Excellence
Apply for awards
Workshops & Courses
Conference FAQ
Upcoming Conference
Scientific Gallery
Publication
About Publication
Journals
Call for Proposal
Books
Publication Support
Journals
Payments
Services
Editing Services
Thesis Writing Services
Journal Management Services
Publication Support
Contact
https://iarconsortium.org/member/
IARC0024
Email
cellsonic.beauty@gmail.com
Share Profile
Andrew Hague
Professor
CellSonic
Biography
Andrew Hague’s interest in the technology that was to become CellSonic began in 1987 with the first lithotripter in Britain. Using his own capital, he developed the CellSonic VIPP machines and sold them around the world. In 2016, Professor Hague devised the protocol for curing cancer and this is now used in CellSonic Clinics in India, Peru, Spain and Poland. Many more are planned. There are no side effects, drugs must not be used and the cancer is stopped immediately. CellSonic VIPP has been used for physiotherapy and sports medicine for twenty years. Where the patient also had cut skin the cure for non-healing wounds was discovered and that led to repairing nerves and pain release. Professor Hague is the owner of CellSonic Limited and founder and chairman of CellSonic (Great Britain) Limited. Medical Research interests Tissue regeneration Cancer - diagnosis and treatment Diabetes - reversal Alzheimer’s disease Parkinson’s disease Genomic analysis
Your profile link has been copied
Copyright © 2020- IARCON International LLP. All rights reserved.